Skip to Content
Contact DCTD
Show menu
Search this site
Last Updated: 03/01/2019

Funding Opportunity Announcements (FOAs)

Funding Opportunities through DCTD’s Programs

Visit the websites of DCTD's individual programs for more information on currently available funding opportunities.

DCTD-related Cancer Moonshot Funding Opportunities
Title Announcement Number Opening
Date
Expiration Date Activity Code
Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the PDX Development and Trial Centers Research Network (PDXNet) (Clinical Trial Not Allowed) PA-19-174 February 28, 2019 March 29, 2019 Admin Supp
Gene Fusions in Pediatric Sarcomas PA-16-251 September 15, 2017 May 8, 2019 R01
Gene Fusions in Pediatric Sarcomas PA-16-252 September 16, 2017 May 8, 2019 R21
Trans-DCTD Funding Opportunities
Title Announcement Number Opening
Date
Expiration Date Activity Code
NCI Clinical and Translational Exploratory/Developmental Studies (Clinical Trial Optional) PAR-18-020 January 20,
2018
March 23,
2019
R21
Early Phase Clinical Trials in Imaging and Image-Guided Interventions (Clinical Trial Required) PAR-18-011 January 15,
2018
February 15,
2020
R01
Exploratory/Developmental Bioengineering Research Grants (EBRG) (Clinical Trial Optional) PAR-19-150 January 16,
2019
January 8,
2022
R21
DCTD-related Trans-NCI Funding Opportunities
Title Announcement Number Opening
Date
Expiration Date Activity Code
Revision Applications for Validation of Biomarker Assays Developed through NIH-Supported Research Grants PAR-17-003 January 28,
2017
October 29,
2019
R01
Assay Validation of High Quality Markers for Clinical Studies in Cancer (Clinical Trial Not Allowed) PAR-18-317
PAR-18-310
January 14,
2018
October 9,
2020
UH2/UH3
UH3
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (Clinical Trial Required) PAR-18-560 February 15,
2018
January 8,
2021
R01
Academic Research Enhancement Award (Clinical Trial Required) PA-18-343 January 25, 2018 January 8, 2021 R15
Microbial-based Cancer Therapy - Bugs as Drugs (Clinical Trial Not Allowed) PAR-19-193 May 16, 2019 May 8, 2022 R01
Microbial-based Cancer Therapy - Bugs as Drugs (Clinical Trial Not Allowed) PAR-19-194 May 16, 2019 May 8, 2022 R21
DCTD-related Trans-NIH Funding Opportunities
Title Announcement Number Opening
Date
Expiration Date Activity Code
Advancing Cancer Immunotherapy by Mitigating Immune-Related Adverse Events (irAE) (Clinical Trial Not Allowed) RFA-CA-19-044 March 25,
2019
April 26,
2019
U01
Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (Clinical Trial Not Allowed) PAR-18-733 May 16,
2018
September 8,
2019
R03
Serious Adverse Drug Reaction Research PAR-16-274
PAR-16-275
September 4,
2016
September 8,
2019
R21
R01
Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (Clinical Trial Optional) PAR-18-009 November 1,
2017
November 6,
2019
R01
Assay Development and Screening for Discovery of Chemical Probes or Therapeutic Agents PAR-17-438 September 5,
2017
September 8,
2020
R01
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (Clinical Trial Optional) PAR-18-530 February 28,
2018
January 8,
2021
R01
Bioengineering Research Grants (BRG) (Clinical Trial Required) PAR-19-159 January 8,
2019
May 8,
2021
R01
Bioengineering Research Grants (BRG) (Clinical Trial Not Allowed) PAR-19-158 January 8,
2019
January 8,
2022
R01
Exploratory/Developmental Bioengineering Research Grants (EBRG) (Clinical Trial Not Allowed) PAR-19-149 January 16,
2019
January 8,
2022
R21